Literature DB >> 15673870

Sorptive loss of volatile and gaseous anesthetics from in vitro drug application systems.

Takahiro Suzuki1, Ichiro Uchida, Takashi Mashimo.   

Abstract

In in vitro pharmacological experiments, determination of effective concentration values for various anesthetics depends on understanding the exact concentration of the drugs dissolved in physiological solutions. Actual anesthetic concentration may differ from expectations because of drug adsorption, absorption or other loss, especially in tubing. We tested the hypothesis that delivered concentrations of anesthetics decrease when solutions pass through laboratory tubing and investigated such loss by measuring the entering and exiting dissolved concentrations of two volatile (sevoflurane and isoflurane) and two gaseous (nitrous oxide and xenon) anesthetics. We tested solutions passed through tubes (1 m x 2 mm ID x 4 mm OD) made of five different materials (glass, Teflon, polyethylene (PE), polyvinyl chloride (PVC), and silicon rubber). Exiting concentrations of anesthetics were significantly reduced when they were passed through PVC (>33%) and silicon (>43%) tubes. There were no decreases in anesthetic concentrations with glass, Teflon, or PE tubes. When sevoflurane solution flowed through PVC and silicon tubes, it took 20 and 30 min, respectively, after start of flow until the anesthetic loss became negligible. These results indicate that frequently used PVC and silicon tubes, whereas flexible and easy to handle, have serious drawbacks when used in inhaled anesthetic pharmacology experiments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673870     DOI: 10.1213/01.ANE.0000142112.30807.5C

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  2 in total

1.  Inhalative sedation with small tidal volumes under venovenous ECMO.

Authors:  Axel Rand; Peter K Zahn; Thomas A Schildhauer; Christian Waydhas; Uwe Hamsen
Journal:  J Artif Organs       Date:  2018-03-05       Impact factor: 1.731

2.  Volatile Isoflurane in Critically Ill Coronavirus Disease 2019 Patients-A Case Series and Systematic Review.

Authors:  Armin Niklas Flinspach; Kai Zacharowski; Deligiannis Ioanna; Elisabeth Hannah Adam
Journal:  Crit Care Explor       Date:  2020-10-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.